Showing 5,201 - 5,220 results of 18,433 for search 'significant ((((((step decrease) OR (a decrease))) OR (we decrease))) OR (mean decrease))', query time: 0.71s Refine Results
  1. 5201
  2. 5202
  3. 5203
  4. 5204

    Baseline characteristics of participants. by Mei Zhou (269746)

    Published 2025
    “…</p><p>Results</p><p>After DRG implementation, the logarithmic mean of total hospitalization expenditures decreased significantly (3.914 ± 0.837 vs. 3.872 ± 1.004), while rates of unplanned readmissions, unplanned reoperations, postoperative complications, and patient complaints within 30 days increased significantly (3.784% vs 4.214%, 0.083% vs 0.166%, 0.207% vs 0.258%, 3.741% vs 5.133%). …”
  5. 5205

    The framework diagram of this study. by Mei Zhou (269746)

    Published 2025
    “…</p><p>Results</p><p>After DRG implementation, the logarithmic mean of total hospitalization expenditures decreased significantly (3.914 ± 0.837 vs. 3.872 ± 1.004), while rates of unplanned readmissions, unplanned reoperations, postoperative complications, and patient complaints within 30 days increased significantly (3.784% vs 4.214%, 0.083% vs 0.166%, 0.207% vs 0.258%, 3.741% vs 5.133%). …”
  6. 5206

    Glucagon-like peptide-1 receptor agonists, inflammation, and kidney diseases: evidence from Mendelian randomization by Yu-Xuan Yao (21338594)

    Published 2025
    “…</p> <p>After meta-analyses of both discovery and validation cohorts, genetically proxied GLP1R agonist was found to significantly associated with a decreased risk of diabetic nephropathy (OR = 0.72, 95%CI = 0.54–0.97, <i>p</i> = 0.031) and IgA nephropathy (OR = 0.58, 95%CI = 0.36–0.94, <i>p</i> = 0.027). …”
  7. 5207
  8. 5208
  9. 5209
  10. 5210
  11. 5211

    DataSheet1_Apolipoprotein A-I attenuates peritoneal fibrosis associated with peritoneal dialysis by inhibiting oxidative stress and inflammation.ZIP by Jing Lu (120666)

    Published 2024
    “…Yet little is known about apoA-I ’s role in peritoneal dialysis. In this study, by analyzing PD patients (n = 81), we found that decreased apoA/HDL-C ratio is significantly associated with rapid decline in peritoneal function. …”
  12. 5212

    F05 demonstrates additive anti-tumor effects in combination with mAb therapy and reprograms M2 macrophages towards a phagocytotic phenotype. by Keifer G. Kurtz (21416918)

    Published 2025
    “…CD163 MFI is significantly decreased with F05 treatment (p = 0.0089, 55% decrease), but not 1H9 (p = 0.0828, 31% decrease) when compared to RITUX.…”
  13. 5213

    Three-Tier Hierarchical Porous Structure with Ultrafast Capillary Transport for Flexible Electronics Cooling by Peilin Cui (18126360)

    Published 2025
    “…The mesocrack, acting as the main water flow channel, efficiently decreases the flow resistance. The micropore, covered with densely distributed spore-like nanopapillae, creates a heterogeneous wetting surface. …”
  14. 5214

    Three-Tier Hierarchical Porous Structure with Ultrafast Capillary Transport for Flexible Electronics Cooling by Peilin Cui (18126360)

    Published 2025
    “…The mesocrack, acting as the main water flow channel, efficiently decreases the flow resistance. The micropore, covered with densely distributed spore-like nanopapillae, creates a heterogeneous wetting surface. …”
  15. 5215

    Three-Tier Hierarchical Porous Structure with Ultrafast Capillary Transport for Flexible Electronics Cooling by Peilin Cui (18126360)

    Published 2025
    “…The mesocrack, acting as the main water flow channel, efficiently decreases the flow resistance. The micropore, covered with densely distributed spore-like nanopapillae, creates a heterogeneous wetting surface. …”
  16. 5216
  17. 5217

    Bone-related serum chemistry endpoints: Aquamin (180-day treatment group) versus placebo. by Muhammad N. Aslam (6598001)

    Published 2025
    “…<p>A. Serum osteocalcin: Values (ng/mL). B. Serum TRAP5b: Values (mIU/mL). …”
  18. 5218

    Study flow chart. by Raymond Atwine (18574812)

    Published 2025
    “…Age above 50 years was associated with a significantly reduced risk of ADCs (OR: 0.11; 95% CI: 0.03–0.43; p value: 0.002). …”
  19. 5219

    Bar graph showing proportion of NADCs. by Raymond Atwine (18574812)

    Published 2025
    “…Age above 50 years was associated with a significantly reduced risk of ADCs (OR: 0.11; 95% CI: 0.03–0.43; p value: 0.002). …”
  20. 5220

    Baseline characteristics of study participants. by Raymond Atwine (18574812)

    Published 2025
    “…Age above 50 years was associated with a significantly reduced risk of ADCs (OR: 0.11; 95% CI: 0.03–0.43; p value: 0.002). …”